These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35817569)

  • 41. Identification of Risk Factors for Refractory Status Epilepticus.
    Tatro HA; Hamilton LA; Peters C; Rowe AS
    Ann Pharmacother; 2020 Jan; 54(1):14-21. PubMed ID: 31347376
    [No Abstract]   [Full Text] [Related]  

  • 42. Isoflurane in (Super-) Refractory Status Epilepticus: A Multicenter Evaluation.
    Stetefeld HR; Schaal A; Scheibe F; Nichtweiß J; Lehmann F; Müller M; Gerner ST; Huttner HB; Luger S; Fuhrer H; Bösel J; Schönenberger S; Dimitriadis K; Neumann B; Fuchs K; Fink GR; Malter MP;
    Neurocrit Care; 2021 Dec; 35(3):631-639. PubMed ID: 34286464
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Refractory Status Epilepticus: Risk Factors and Analysis of Intubation in the Multicenter SENSE Registry.
    Beuchat I; Rosenow F; Kellinghaus C; Trinka E; Unterberger I; Rüegg S; Sutter R; Tilz C; Uzelac Z; Rossetti AO; Strzelczyk A
    Neurology; 2022 Oct; 99(16):e1824-e1834. PubMed ID: 35948449
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ketamine to treat super-refractory status epilepticus.
    Alkhachroum A; Der-Nigoghossian CA; Mathews E; Massad N; Letchinger R; Doyle K; Chiu WT; Kromm J; Rubinos C; Velazquez A; Roh D; Agarwal S; Park S; Connolly ES; Claassen J
    Neurology; 2020 Oct; 95(16):e2286-e2294. PubMed ID: 32873691
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of Continuous Ketamine Infusion as an Adjunctive Agent in Young Infants With Refractory and Super Refractory Status Epilepticus: A Case Series.
    DeVine MN; Gordon SE; Press CA
    J Pediatr Pharmacol Ther; 2023; 28(2):161-166. PubMed ID: 37139250
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Refractory Status Epilepticus in Children: Intention to Treat With Continuous Infusions of Midazolam and Pentobarbital.
    Tasker RC; Goodkin HP; Sánchez Fernández I; Chapman KE; Abend NS; Arya R; Brenton JN; Carpenter JL; Gaillard WD; Glauser TA; Goldstein J; Helseth AR; Jackson MC; Kapur K; Mikati MA; Peariso K; Wainwright MS; Wilfong AA; Williams K; Loddenkemper T;
    Pediatr Crit Care Med; 2016 Oct; 17(10):968-975. PubMed ID: 27500721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study.
    Kantanen AM; Reinikainen M; Parviainen I; Kälviäinen R
    Epilepsy Res; 2017 Jul; 133():13-21. PubMed ID: 28402834
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors associated with long-term outcomes in pediatric refractory status epilepticus.
    Gaínza-Lein M; Barcia Aguilar C; Piantino J; Chapman KE; Sánchez Fernández I; Amengual-Gual M; Anderson A; Appavu B; Arya R; Brenton JN; Carpenter JL; Clark J; Farias-Moeller R; Gaillard WD; Glauser TA; Goldstein JL; Goodkin HP; Huh L; Kahoud R; Kapur K; Lai YC; McDonough TL; Mikati MA; Morgan LA; Nayak A; Novotny E; Ostendorf AP; Payne ET; Peariso K; Reece L; Riviello J; Sannagowdara K; Sands TT; Sheehan T; Tasker RC; Tchapyjnikov D; Vasquez A; Wainwright MS; Wilfong A; Williams K; Zhang B; Loddenkemper T;
    Epilepsia; 2021 Sep; 62(9):2190-2204. PubMed ID: 34251039
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intensive care treatment of uncontrolled status epilepticus in children: systematic literature search of midazolam and anesthetic therapies*.
    Wilkes R; Tasker RC
    Pediatr Crit Care Med; 2014 Sep; 15(7):632-9. PubMed ID: 24901802
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Midazolam and thiopental for the treatment of refractory status epilepticus: a retrospective comparison of efficacy and safety.
    Bellante F; Legros B; Depondt C; Créteur J; Taccone FS; Gaspard N
    J Neurol; 2016 Apr; 263(4):799-806. PubMed ID: 26914931
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety and Efficacy of Ketamine Without Intubation in the Management of Refractory Seizures: A Case Series.
    Kimmons LA; Alzayadneh M; Metter EJ; Alsherbini K
    Neurocrit Care; 2024 Apr; 40(2):689-697. PubMed ID: 37610640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus.
    Claassen J; Hirsch LJ; Emerson RG; Bates JE; Thompson TB; Mayer SA
    Neurology; 2001 Sep; 57(6):1036-42. PubMed ID: 11571331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Status epilepticus: Refractory and super-refractory.
    Dubey D; Kalita J; Misra UK
    Neurol India; 2017; 65(Supplement):S12-S17. PubMed ID: 28281491
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-Dose Midazolam for Pediatric Refractory Status Epilepticus: A Single-Center Retrospective Study.
    Daniels ZS; Srdanovic N; Rychlik K; Smith C; Goldstein J; George AL
    Pediatr Crit Care Med; 2022 Nov; 23(11):929-935. PubMed ID: 35894600
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors Associated with Refractory Status Epilepticus Termination Following Ketamine Initiation: A Multivariable Analysis Model.
    Srinivas M; Parker D; Millis S; Marawar R; Zutshi D; Basha MM
    Neurocrit Care; 2023 Apr; 38(2):235-241. PubMed ID: 36002634
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Uric acid is a useful marker to differentiate between responsive and refractory status epilepticus.
    Choi JY; Hong JM; Kim TJ; Kim BG; Huh K
    Clin Neurol Neurosurg; 2019 Sep; 184():105454. PubMed ID: 31376771
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and Safety of Ketamine in Refractory/Super-refractory Nonconvulsive Status Epilepticus: Single-Center Experience.
    Dericioglu N; Arslan D; Arsava EM; Topcuoglu MA
    Clin EEG Neurosci; 2021 Sep; 52(5):345-350. PubMed ID: 32752882
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lacosamide in children with refractory status epilepticus. A multicenter Italian experience.
    Grosso S; Zamponi N; Bartocci A; Cesaroni E; Cappanera S; Di Bartolo R; Balestri P
    Eur J Paediatr Neurol; 2014 Sep; 18(5):604-8. PubMed ID: 24836405
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The efficacy of topiramate in adult refractory status epilepticus: experience of a tertiary care center.
    Synowiec AS; Yandora KA; Yenugadhati V; Valeriano JP; Schramke CJ; Kelly KM
    Epilepsy Res; 2012 Feb; 98(2-3):232-7. PubMed ID: 22000869
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Refractory status epilepticus: frequency, risk factors, and impact on outcome.
    Mayer SA; Claassen J; Lokin J; Mendelsohn F; Dennis LJ; Fitzsimmons BF
    Arch Neurol; 2002 Feb; 59(2):205-10. PubMed ID: 11843690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.